https://de.marketscreener.com/kurs/aktie/TRACON-PHARMACEUTICALS-IN-20566490/news/TRACON-Pharmaceuticals-gibt-bekannt-dass-die-Phase-2-Zulassungsstudie-ENVASARC-bei-der-abschlie-en-44867463/?utm_source=telegram&utm_medium=social&utm_campaign=share